Skip to main content
logo
Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.6870
+0.0516 (8.12%)
At close: Nov 6, 2026, 4:00 PM EST
0.6701
-0.0169 (-2.46%)
After-hours: Nov 6, 2026, 6:18 PM EST

Cognition Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
10.1210.6112.2913.5313.2310.03
Research & Development
27.4937.1941.6837.230.3218.57
Operating Expenses
37.647.853.9750.7243.5528.6
Operating Income
-37.6-47.8-53.97-50.72-43.55-28.6
Interest Expense
-0.01-0.01-0.03-0.03-0.03-0.89
Currency Exchange Gain (Loss)
---0.2---
Other Non Operating Income (Expenses)
21.6324.3320.2224.9622.1817.33
EBT Excluding Unusual Items
-15.99-23.49-33.97-25.79-21.4-12.16
Other Unusual Items
-----0.44
Pretax Income
-15.99-23.49-33.97-25.79-21.4-11.72
Net Income
-15.99-23.49-33.97-25.79-21.4-11.72
Preferred Dividends & Other Adjustments
-----4.53
Net Income to Common
-15.99-23.49-33.97-25.79-21.4-16.25
Net Income Growth
------
Shares Outstanding (Basic)
91734030245
Shares Outstanding (Diluted)
91734030245
Shares Change
47.11%83.15%32.31%27.03%355.42%921.60%
EPS (Basic)
-0.18-0.32-0.86-0.86-0.91-3.13
EPS (Diluted)
-0.18-0.32-0.86-0.86-0.91-3.13
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-15.31-24.59-28.48-16.17-18.7-3.66
Free Cash Flow Per Share
-0.17-0.34-0.72-0.54-0.79-0.70
EBITDA
-37.56-47.76-53.86-50.63-43.47-28.51
D&A For EBITDA
0.050.040.110.10.080.09
EBIT
-37.6-47.8-53.97-50.72-43.55-28.6
SEC Filings: 10-K · 10-Q